Cloning, expression, purification of rat tumor necrosis factor and demonstration of its antitumor activity in Bomirski amelanotic melanoma

Neoplasma

Volumn 45, Issue 3, 1998, Pages 162-168

  KoszaLka P ^a   Breza, H ^a   Bigda, J ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Antitumor activity; Cloning; Melanoma; Rat; TNF

Indexed keywords

TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA;

AMELANOTIC MELANOMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER IMMUNOLOGY; CANCER INHIBITION; CONTROLLED STUDY; MOLECULAR CLONING; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PURIFICATION; RAT; SYRIAN HAMSTER;

EID: 0031815163     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. BALICKI, A., JURKIEWICZ, B.: Statistical Methods in Biology. Gdańsk, University of Gdańsk 1989.
2. BEYAERT R., FIERS, W.: Molecular mechanisms of tumor necrosis factor-induced cytotoxicity: What we understand and what we do not. FEBS Lett., 340, 1994, 9-16.
3. BLACK, R.A., RAUCH, C.T., KOZLOSSKY, C.J., PESCHON, J.J., SLACK, J.L., WOLFSON, M.F., CASTNER, B.J., STOCKING, K.L., REDDY, P., SRINIVASAN, S., NELSON, N., BOIANI, N., SCHOOLEY, K.A., GERHART, M., DAVIS, R., FITZNER, J.N., JOHNSON, R.S., PAXTON, R.J., MARCH, C.J., CERRETTI, D.P.: A metalloproteinase disintegrin that releases tumour necrosis factor-alpha from cells. Nature, 385, 1997, 729-733.
4. BOMIRSKI, A., SŁOMIŃSKI, A., BIGDA, J.: The natural history of a family of transplantable melanomas in hamsters. Cancer Metastasis Rev., 7, 1988, 95-118.
5. CARSWELL, E.A., OLD, L.J., KASSEL, S., GREEN, S., FIORE, N., WILLLAMSON, B.: An endotoxin-induced serum factor that causes necrosis of tumors. Proc. Natl. Acad. Sci. USA, 72, 1975, 3666-3670.
6. CHOMCZYNSKI, P., SACCHI, N.: Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 161, 1987, 156-159.
7. EGGERMONT, A.M., SCHRAFFORDT KOOPS H., KLAUSNER, J.M., KROON, B.B., SCHLAG, P.M., LIENARD, D., VAN GEEL, A.N., HOEKSTRA, H.J., MELLER, I., NIEWEG, O.E., KETTELHACK, C., BEN-ARI, G., PECTOR, J.C., LEJEUNE, F.J.: Isolated limb perfusion with tumor necrosis factor and melphalan for limb salvage in 186 patients with locally advanced soft tissue extremity sarcomas. The cumulated multicenter European experience. Ann. Surg., 224, 1996, 756-764.
8. LEWIS, M., TARTAGLIA, L.A., LEE, A., BENNETT, G.L., RICE, G.C., WONG, G.H.W., CHEN, E.Y., GOEDDEL, D.V.: Cloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific. Proc. Natl. Acad. Sci. USA, 88, 1991, 2830-2834.
9. Moss, M.L., JIN, S.L., BECHERE, J.D., JIN, S.L., BECHERE, J.D., BICKETT, D.M., BURKHART, W., CHEN, W.J., HASSLER, D., LEESNITZER, M.T., MCGEEHAN, G., MILLA, M., MOYER, M., ROCQUE, W., SEATON, T., SCHOENE, F., WARNER, J., WILLARD, D.: Structural features and biochemical properties of TNF-alpha converting enzyme (TACE). J. Neuroimmunol., 72, 1997, 127-129.
10. MYŚLIWSKI, A., BIGDA, J., MYŚLIWSKA, J., WITKOWSKI, J., SOSNOWSKA, D.: Changes of natural killer cytotoxic activity and natural killer sensitivity during growth of Bomirski melanotic (Ma) and amelanotic (Ab) melanomas. Neoplasma, 42, 1995, 15-19.
11. MYSLIWSKI, A., SOSNOWSKA, D., BIGDA, J.: Effect of tumor excision on NK cytotoxic activity and formation of metastases of Bomirski melanoma in hamsters. Neoplasma, 43, 1996, 311-313.
12. PAQUET, A., LEVESQUE, A., PAGE, M.: Rapid purification method for human recombinant tumor necrosis factor alpha. J. Chromatogr. A, 667, 1994, 125-130.
13. ROBACHE-GALLEA, S., BRUNEAU, J.M., ROBBE, H., MORAND, V., CAPDEVILA, C., BHATNAGAR, N., CHOUAIB, S., ROMAN-ROMAN, S.: Partial purification and characterization of a tumor necrosis factor-alpha converting activity. Eur. J. Immunol., 27, 1997, 1275-1282.
14. SCHOENFELD, H., POESCHL, B., FREY, J.R., LOETSCHER, H., HUNZIKER, W., LUSTIG, A., ZULAUF, M.: Efficient purification of recombinant human tumor necrosis factor ß from Escherichia coli yields biologically active protein with a trimeric structure that binds to both tumor necrosis factor receptors. J. Biol. Chem., 266, 1991, 3863-3869.
15. SLOMINSKI, A., PAUS, R.: Bomirski melanomas: A versatile and powerful model for pigment cell and melanoma research. Int. J. Oncol., 2, 1993, 221-228.
16. SHIRAI, T., SHIMIZU, N., HORIGUCHI, S., ITO, H.: Cloning and expression in Escherichia coli of the gene for rat tumor necrosis factor. Agricot. Biol. Chem., 53, 1989, 1733-1736.
17. SMITH, R.A., BAGLIONI, C.: The active form of tumor necrosis factor is a trimer. J, Biol. Chem., 262, 1987, 6951-6954.
18. SUGARMAN, B.J, AGGARWAL, B.B., HASS, P.E., FIGARI, I.S., PALLADINO, M.A., SHEPARD, H.M.: Recombinant human tumor necrosis factor-α: Effects on proliferation of normal and transformed cells in vitro. Science, 230, 1985, 943-945.
19. TARTAGLIA, L.A., GOEDDEL, D.V.: Two TNF receptors. Immunol. Today, 13, 1992, 151-153.
20. VILCEK, J., LEE, T.H.: Tumor necrosis factor - new insight into the molecular mechanisms of its multiple actions. J. Biol. Chem., 266, 1991, 7313-7316.
21. WALLACH, D.: Preparations of lymphotoxin induce resistance to their own cytotoxic effect. J. Immunol., 132, 1984, 2464-2469.